Immunogenicity of a bovine herpes virus i peptide expressed in tandem copies in attenuated Salmonella

Viral Immunology

Volumn 25, Issue 1, 2012, Pages 63-72

  Gnazzo, Victoria ^a   Cebrian, Ignacio ^a   Langellotti, Cecilia ^b   Chabalgoity, José ^d   Mongini, Claudia ^b   Quattrocchi, Valeria ^a   Zamorano, Patricia ^a,b,c  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSIDAD DEL SALVADOR   (Argentina)

^d Universidad de la Republica Instituto de Higiene   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN D; PLASMID VECTOR; SYNTHETIC PEPTIDE; TETANUS TOXIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE HERPES VIRUS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RELEASE; DRUG RESPONSE; EXPRESSION VECTOR; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CELL LINE; GENETIC VECTORS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; LYMPHOCYTE ACTIVATION; LYMPHOKINES; MICE; MICE, INBRED BALB C; PEPTIDES; SALMONELLA TYPHIMURIUM; TANDEM REPEAT SEQUENCES; VIRAL PROTEINS; VIRAL VACCINES;

BOVINAE; BOVINE HERPESVIRUS 1; HERPESVIRIDAE; MUS; SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 84856726414     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2011.0031     Document Type: Article

References (32)

1. Abdelmagid OY, Minocha HC, Collins JK, and Chowdhury SI: Fine mapping of bovine herpesvirus-1 (BHV-1) glycoprotein D (gD) neutralizing epitopes by type-specific monoclonal antibodies and sequence comparison with BHV- 5 gD. Virology 1995;206:242-253.
2. Babiuk LA, L'Italien J, van Drunen Littel-van den Hurk S, Zamb T, Lawman JP, Hughes G, and Gifford GA: Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins. Virology 1987;159:57-66.
3. Baillie LW, Rodriguez AL, Moore S, Atkins HS, Feng C, Nataro JP, and Pasetti MF: Towards a human oral vaccine for anthrax: the utility of a Salmonella typhi Ty21a-based prime-boost immunization strategy. Vaccine 2008;26:6083-6091.
4. Chabalgoity JA, Khan CM, Nash AA, and Hormaeche CE: A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol Microbiol 1996;19:791-801.
5. Chase CC, and Letchworth GJ 3rd: Bovine herpesvirus 1 gIV-expressing cells resist virus penetration. J Gen Virol 1994;75(Pt 1):177-181. (Pubitemid 24033995)
6. Chinchilla M, Pasetti MF, Medina-Moreno S, et al.: Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy. Infect Immun 2007;75: 3769-3779. (Pubitemid 47206274)
7. Denis M, Slaoui M, Keil G, Babiuk LA, Ernst E, Pastoret PP, and Thiry E: Identification of different target glycoproteins for bovine herpes virus type 1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. Immunology 1993;78:7-13. (Pubitemid 23035842)
8. Deshpande MS, Ambagala TC, Hegde NR, Hariharan MJ, Navaratnam M, and Srikumaran S: Induction of cytotoxic Tlymphocytes specific for bovine herpesvirus-1 by DNA immunization. Vaccine 2002;20:3744-3751. (Pubitemid 35223405)
9. Dunstan SJ, Simmons CP, and Strugnell RA: Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen. Infect Immun 1998;66:732-740. (Pubitemid 28074220)
10. Echchannaoui H, Bianchi M, Baud D, Bobst M, Stehle JC, and Nardelli-Haefliger D: Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer. Infect Immun 2008;76:1940-1951. (Pubitemid 351656127)
11. Engels M, and Ackermann M: Pathogenesis of ruminant herpesvirus infections. Vet Microbiol 1996;53:3-15. (Pubitemid 27013940)
12. Fraillery D, Baud D, Pang SY, et al.: Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Clin Vaccine Immunol 2007;14:1285-1295. (Pubitemid 350012970)
13. Galan JE, and Curtiss R 3rd: Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb Pathog 1989;6:433-443. (Pubitemid 19223598)
14. Griebel PJ, Ohmann HB, Lawman MJ, and Babiuk LA: The interaction between bovine herpesvirus type 1 and activated bovine T lymphocytes. J Gen Virol 1990;(Pt 2):369-377. (Pubitemid 20059134)
15. Huang JM, Sali M, Leckenby MW, et al.: Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector. Vaccine 2010;28:7523-7528.
16. Hutchings DL, Campos M, Qualtiere L, and Babiuk LA: Inhibition of antigen-induced and interleukin-2-induced proliferation of bovine peripheral blood leukocytes by inactivated bovine herpes virus 1. J Virol 1990;64:4146-4151. (Pubitemid 20279821)
17. Karem KL, Chatfield S, Kuklin N, and Rouse BT: Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infect Immun 1995;63:4557-4563.
18. Khan CM, Villarreal-Ramos B, Pierce RJ, et al.: Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella. J Immunol 1994;153:5634-5642.
19. Khan CM, Villarreal-Ramos B, Pierce RJ, et al.: Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc Natl Acad Sci USA 1994;91:11261-11265.
20. Langellotti CA, Pappalardo JS, Quattrocchi V, Mongini C, and Zamorano P: Induction of specific cytotoxic activity for bovine herpesvirus-1 by DNA immunization with different adjuvants. Antiviral Res 2011;90:134-142.
21. Miethke A, Keil GM, Weiland F, and Mettenleiter TC: Unidirectional complementation between glycoprotein B homologues of pseudorabies virus and bovine herpesvirus 1 is determined by the carboxy-terminal part of the molecule. J Gen Virol 1995;76(Pt 7):1623-1635.
22. Miller SI, Kukral AM, and Mekalanos JJ: A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci USA 1989;86:5054-5058. (Pubitemid 19182231)
23. Muylkens B, Thiry J, Kirten P, Schynts F, and Thiry E: Bovine herpesvirus 1 infection and infectious bovine rhinotracheitis. Vet Res 2007;38:181-209. (Pubitemid 46557873)
24. Nataraj C, Eidmann S, Hariharan MJ, Sur JH, Perry GA, and Srikumaran S: Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules. Viral Immunol 1997;10:21-34. (Pubitemid 27168271)
25. Oliveira SC, Harms JS, Rosinha GM, Rodarte RS, Rech EL, and Splitter GA: Biolistic-mediated gene transfer using the bovine herpesvirus-1 glycoprotein D is an effective delivery system to induce neutralizing antibodies in its natural host. J Immunol Methods 2000;245:109-118.
26. Spear PG, Eisenberg RJ, and Cohen GH: Three classes of cell surface receptors for alphaherpesvirus entry. Virology 2000;275:1-8.
27. Tikoo SK, Campos M, Popowych YI, van Drunen Littel-van den Hurk S, and Babiuk LA: Lymphocyte proliferative responses to recombinant bovine herpes virus type 1 (BHV-1) glycoprotein gD (gIV) in immune cattle: identification of a T cell epitope. Viral Immunol 1995;8:19-25.
28. Valmori D, Pessi A, Bianchi E, and Corradin G: Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J Immunol 1992;149:717-721.
29. van Drunen Littel-van den Hurk S, Snider M, Thompson P, Latimer L, and Babiuk LA: Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies. Vaccine 2008;26:3103-3111.
30. Van Refenmortel M, Bishop FCD, Carstens E, et al.: Family Herpesviridae. In: Virus Taxonomy. Classification and Nomenclature of Viruses, Seventh Report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego, pp 203-225.
31. Whetstone CA, Sayre KR, Dock NL, VanDerMaaten MJ, Miller JM, Lillehoj E, and Alexander SS: Examination of whether persistently indeterminate human immunodeficiency virus type 1 Western immunoblot reactions are due to serological reactivity with bovine immunodeficiency-like virus. J Clin Microbiol 1992;30:764-770.
32. Zamorano, P., O. Taboga, M. Dominguez, A. Romera, M. Puntel, C. Tami, C. Mongini, C. Waldner, E. Palma and A. Sadir: BHV-1 DNA vaccination: effect of the adjuvant RN-205 on the modulation of the immune response in mice. Vaccine 2002;20:2656-2664. (Pubitemid 34600998)